Company
Biohemp International, Inc.
Headquarters: New York, NY, United States
Employees: 1
CEO: Mr. Daniel Blum
Biohemp International, Inc. Categories
United States Healthcare Drug Manufacturers—Specialty & GenericUnited States Healthcare United States Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
BioHemp International, Inc. focuses on operating in the fast-growing consumer hemp and cannabidiol (CBD) market through a strategic rollup of CBD distributors. It focuses on the creation of distribution platform for CBD providers. The company was formerly known as Blake Insomnia Therapeutics, Inc. and changed its name to BioHemp International, Inc. in June 2019. BioHemp International, Inc. was founded in 2012 and is based in New York, New York.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Biohemp International, Inc. has the following listings and related stock indices.
Stock: OTC: BKIT wb_incandescent